Kyle Greenway developed the Montreal Model to pair ketamine with psychotherapy. In this 3-part series, he shows us how to do it. 

Did boundary violations sink MDMA-assisted therapy, or was there something more? In part II of our series, we look at what else went wrong.

Did boundary violations sink MDMA assisted psychotherapy? We explore the reasons behind the FDA panel’s rejection of this psychedelic therapy.

0.25 CME Credits. Psychiatric news covered in this episode: TMS for Teens, Olanzapine Serum Levels, Old Medication Pairing Emerges for Novel Alcoholism Treatment, Old Medication Pairing Emerges for Novel Alcoholism Treatment, Promising Option For Transitioning Insomnia Medications, Lithium's Anti-Suicide Effects in Question, Role of Omega-3 Supplements in Psychosis Risk Reduction, Caffeine and Anxiety: A Concerning Connection for Coffee Lovers.

A psychotherapeutic plan to make ketamine’s benefits last.